| 000 | 01805 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517124548.0 | ||
| 264 | 0 | _c20171116 | |
| 008 | 201711s 0 0 cze d | ||
| 022 | _a1211-9059 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMlčáková, E | |
| 245 | 0 | 0 |
_a[Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent]. _h[electronic resource] |
| 260 |
_bCeska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti _c |
||
| 300 |
_a120-127 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzalkonium Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aConjunctival Diseases _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorophotometry |
| 650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperemia _xchemically induced |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 |
_aPolymers _xadministration & dosage |
| 650 | 0 | 4 |
_aPreservatives, Pharmaceutical _xadministration & dosage |
| 650 | 0 | 4 |
_aProstaglandins F, Synthetic _xadministration & dosage |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMlčák, P | |
| 700 | 1 | _aKarhanová, M | |
| 700 | 1 | _aLangová, K | |
| 700 | 1 | _aMarešová, K | |
| 773 | 0 |
_tCeska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti _gvol. 72 _gno. 4 _gp. 120-127 |
|
| 999 |
_c26616609 _d26616609 |
||